TetraLogic Pharmaceuticals Operating Income

TetraLogic Pharmaceuticals (TLOG) currently reports a operating income of $-37M as of September 2016. That compares with $-42M in the prior-year period — up 12.7% year over year. Use the charts on this page to explore TetraLogic Pharmaceuticals's operating income history and peer comparisons.

TetraLogic Pharmaceuticals's operating income increased from $-42M to $-37M — a 12.7% year-over-year increase (period ending September 2016). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

TetraLogic Pharmaceuticals reported $-37M in operating income as of September 2016. That compares with $-42M in the prior-year period — up 12.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-37M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for TetraLogic Pharmaceuticals, and consider following TLOG for alerts when major investors trade the stock.

TetraLogic Pharmaceuticals is classified in the Healthcare sector. On operating income, it currently shows $-37M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TLOG with unrelated industries.